Send the following on WhatsApp
Continue to Chat第一個肺癌術後標靶療法獲 FDA 核准! Osimertinib 造福早期患者 https://geneonline.news/fda-approve-osimertinib-as-first-adjuvant-therapy-for-nsclc/
第一個肺癌術後標靶療法獲 FDA 核准! Osimertinib 造福早期患者 https://geneonline.news/fda-approve-osimertinib-as-first-adjuvant-therapy-for-nsclc/